![Paul Perreault](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Paul Perreault
Verkställande Direktör på
CSL Behring AB
Profil
Paul Roger Perreault is currently the Chief Executive Officer at CSL Behring AB and CSL Finance Plc.
He is also a Director at Pharmaceutical Research & Manufacturers of America.
Previously, he served as the Chief Executive Officer, Executive Director & MD at CSL Ltd. from 2013 to 2023.
He has also held positions such as Chairman-Global Board at Plasma Protein Therapeutics Association, Business Director at Wyeth-Ayerst Research, Vice President & General Manager at Aventis Bio-Services, Inc. and Aventis Behring, and President at CSL Behring LLC from 2011 to 2013.
Perreault received his undergraduate degree from the University of Central Florida.
Aktiva positioner av Paul Perreault
| Företag | Position | Start |
|---|---|---|
CSL Behring AB
 CSL Behring AB Pharmaceuticals: MajorHealth Technology Develops and delivers therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease and neurological disorders | Verkställande Direktör | - |
Pharmaceutical Research & Manufacturers of America
 Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Direktör/Styrelseledamot | 2020-12-01 |
CSL Finance Plc
 CSL Finance Plc Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Verkställande Direktör | - |
Tidigare kända positioner av Paul Perreault
| Företag | Position | Slut |
|---|---|---|
| CSL LIMITED | Verkställande Direktör | 2023-03-06 |
Plasma Protein Therapeutics Association
 Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services Non-profit organization representing manufacturers and plasma collection centers | Ordförande | - |
Aventis Behring
 Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Företagsledare/Principal | - |
Aventis Bio-Services, Inc.
 Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Företagsledare/Principal | - |
Wyeth-Ayerst Research | Företagsledare/Principal | - |
Paul Perreaults utbildningar
Erfarenheter
Innehade positioner
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Relationer
61
Första gradens relationer
10
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
Kopplade företag
| Privata företag | 10 |
|---|---|
CSL Ltd.
 CSL Ltd. BiotechnologyHealth Technology Develops and manufactures medicines that treat people with rare and serious diseases | Health Technology |
Plasma Protein Therapeutics Association
Plasma Protein Therapeutics Association Miscellaneous Commercial ServicesCommercial Services Non-profit organization representing manufacturers and plasma collection centers | Commercial Services |
Aventis Bio-Services, Inc.
Aventis Bio-Services, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
Aventis Behring
Aventis Behring Pharmaceuticals: MajorHealth Technology Develops pharmaceutical and agricultural products | Health Technology |
University of Central Florida
 University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology Manufactures and markets plasma protein products | Health Technology |
Pharmaceutical Research & Manufacturers of America
Pharmaceutical Research & Manufacturers of America BiotechnologyHealth Technology Provides pharmaceutical research and biotechnology services | Health Technology |
Wyeth-Ayerst Research | |
CSL Behring AB
CSL Behring AB Pharmaceuticals: MajorHealth Technology Develops and delivers therapies that are used to treat coagulation disorders, primary immune deficiencies, hereditary angioedema, inherited respiratory disease and neurological disorders | Health Technology |
CSL Finance Plc
CSL Finance Plc Finance/Rental/LeasingFinance Functions as a financing subsidiary/special purpose entity | Finance |
